ALFA FinderBSE filing, NSE: VADILALIND. Summary written from the filing by ALFA Finder's alert engine.
Vadilal Industries Ltd: key numbers
- Share price
- ₹6,987.50
- Market cap
- ₹5,022 Cr
- Revenue (annual)
- ₹1,503 Cr
- Net profit (annual)
- ₹155.1 Cr
- P/E (TTM)
- 20.5×Sector 41.3×
- Promoter holding
- 64.72%-0.01% QoQ
- FII holding
- 1.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vadilal Industries Ltd
All →Vadilal Industries Q2 FY27 Results: Net Profit ₹54.8 Cr, Up 64.1% YoY
Vadilal Industries Ltd reported revenue from operations of ₹462.6 Cr (+35.3% YoY) and net profit of ₹54.8 Cr (+64.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹54.8 Cr · +64.1% YoY
Vadilal Industries Annual General Meeting
Vadilal Industries shareholders met at an EGM on 27 October 2026 to consider a single ordinary resolution approving a sale and purchase agreement with Vadilal Enterprises Limited. The filing gives no transaction value, and the meeting concluded at 11:45 A.M.
Vadilal Industries Board Meeting Date
Vadilal Industries will hold a board meeting on 30 October 2026 to consider Q2 and H1 results. The trading window stays closed until 1 November 2026.
Vadilal Industries Other Announcement
Vadilal Industries Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations for the quarter ended September 30, 2026.
Vadilal Industries Annual General Meeting
Vadilal Industries Limited issued an EGM notice for October 27, 2026. Shareholders will consider approving a sale and purchase agreement with Vadilal Enterprises Limited.
Vadilal Industries Annual General Meeting
Vadilal Industries Limited issued a notice for an Extraordinary General Meeting on October 27, 2026. Shareholders will vote on a Rs. 1,426 Crore supply agreement with Vadilal Enterprises Limited.
- Value
- ₹1,426 Cr
- From
- Vadilal Enterprises Limited
- Execution
- 12 months
Other business update announcements
All →Suven Life Sciences Business Update
Suven Life Sciences will present seven posters on its CNS pipeline at Neuroscience 2026, Washington DC. Presentations span Phase-3 and preclinical candidates targeting neurodegenerative and neuropsychiatric disorders.
Smruthi Organics Business Update
Smruthi Organics received the Brazilian GMP (CBPF) certificate for its Unit II API, Levamlodipine Besylate Hemi pentahydrate. This strengthens its regulatory presence in the Brazilian pharmaceutical market.
Kreon Finnancial Services Business Update
Kreon Financial Services launched StuCred for Startups, a mentorship initiative for student entrepreneurs. No revenue projection or monetary value is attached to the new program.
Aurobindo Pharma Business Update
Aurobindo Pharma disclosed that US FDA classified its Lannett facility inspection as Official Action Indicated (OAI). The company states there is no quantifiable financial or operational impact.
Gokaldas Exports Business Update
Gokaldas Exports issued a press release clarifying a customer's Chapter 11 filing, which involves USD 4.11 million of receivables held by its African subsidiary Atraco. It also reports two new customers onboarded in its African operations.
Adani Enterprises Business Update
Adani Enterprises' Kutch Copper became the first Indian producer to receive the Copper Mark certification. It recognises responsible copper production under independent ESG audits.